Dentons has advised GeneProof founders Radek Horvath and Milos Dendis on the company’s merger with the American Laboratory Products Company, leading to the establishment of the ALPCO Group. Glatzova & Co and Sidley Austin advised the Silicon Valley Bank on financing the merger. Goodwin Procter and Schoenherr reportedly advised Ampersands, the owner of ALPC.
According to Dentons, “the main shareholders of the new group will be Ampersand Capital Partners, a US private equity fund, Radek Horvath, and Milos Dendis.”
GeneProof is a Czech molecular diagnostics company that provides customers with solutions in the field of molecular in vitro diagnostics of serious infections and genetic diseases.
The American Laboratory Products Company is a US specialty in vitro diagnostics company.
Silicon Valley Bank is a US-based high-tech commercial bank specializing in lending to technology companies and providing multiple services to venture capital, revenue-based financing, and private equity firms that invest in technology and biotechnology.
According to Dentons, “the ALPCO Group aims to become a global market leader in the diagnostic products market, with broad capabilities spanning novel immunoassay testing kits, real-time PCR testing products, and automated laboratory instrumentation solutions.”
Dentons’ Prague-based team included Partners Jan Prochazka and Daniel Hurych, Senior Associates Vojtech Novak and Adam Prerovsky, Associates Ondrej Vales and Michal Pelikan, Junior Associate Blanka Crhakova, and Honorary Member Petr Kotab, with the help of New York-based Partner Ilan Katz.
The Glatzova & Co team included Partner Libor Nemec, Managing Associate Jarmila Tornova, and Junior Associate Tomas Farnik.